Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BVS
MLTX
Add up to 3 more stocks
BVS
Bioventus Inc.
-1.78%
$13.28-0.24Delayed quote: Oct 6, 2026, 12:15 PM EDT
Market Cap
$899.69M
52W Range
$6.37 - $15.89
MLTX
MoonLake Immunotherapeutics
-1.19%
$11.24-0.14Delayed quote: Oct 6, 2026, 12:10 PM EDT
Market Cap
$945.88M
52W Range
$8.18 - $23.29
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 17.24 | N/A |
| Forward P/E | 17.05 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.94 | 2.21 |
| P/S Ratio | 1.55 | N/A |
| P/FCF Ratio | 9.54 | N/A |
| EV/EBITDA | 10.59 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 68.0% | 0.0% |
| Operating Margin | 10.6% | 0.0% |
| Net Margin | 9.4% | 0.0% |
| ROE | 23.9% | -61.6% |
| ROA | 8.1% | -45.9% |
| ROIC | 11.4% | -50.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.69 | 12.56 |
| Quick Ratio | 1.17 | 12.56 |
| Debt/Equity | 1.16 | 0.24 |
| Interest Coverage | 2.21 | -33.78 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.